These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 18957384

  • 1. Blockade of calcineurin reverses cardiac hypertrophy and induces the down-regulation of JNK mRNA expression in renovascular hypertensive rats.
    Hongzhuan Sheng, Jianhua Zhu, Xiaohui Wu, Jinan Zhang.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):139-45. PubMed ID: 18957384
    [Abstract] [Full Text] [Related]

  • 2. [Role of calcineurin in the progression of cardiac hypertrophy in renovascular hypertensive rats].
    Sheng HZ, Zhang JN, Yang D, Yang GP, Xu JD, Chen XJ.
    Sheng Li Xue Bao; 2003 Oct 25; 55(5):594-8. PubMed ID: 14566410
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats.
    Sheng H, Zhu J, Wu X, Yang D, Zhang J.
    Hypertens Res; 2007 Dec 25; 30(12):1247-54. PubMed ID: 18344631
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD.
    Cardiovasc Res; 2004 Aug 15; 63(3):467-75. PubMed ID: 15276472
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y, Huang Q, Abe J, Glassman M, Che W, Lee JD, Kawakatsu H, Lawrence EG, Hoit BD, Berk BC, Walsh RA.
    J Mol Cell Cardiol; 2001 Sep 15; 33(9):1637-48. PubMed ID: 11549343
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Normalization of the calcineurin pathway underlies the regression of hypertensive hypertrophy induced by Na+/H+ exchanger-1 (NHE-1) inhibition.
    Ennis IL, Garciarena CD, Escudero EM, Pérez NG, Dulce RA, Camilión de Hurtado MC, Cingolani HE.
    Can J Physiol Pharmacol; 2007 Sep 15; 85(3-4):301-10. PubMed ID: 17612638
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension].
    Shimoyama M, Hayashi D, Zou Y, Takimoto E, Mizukami M, Monzen K, Yazaki Y, Nagai R, Komuro I.
    J Cardiol; 2001 Feb 15; 37(2):114-8. PubMed ID: 11255695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.